- 全部删除
- 您的购物车当前为空
GJG057是一种高效和选择性的Leukotriene C4 synthase (LTC4S)抑制剂,在人全血LTC4释放试验中IC50=44 nM且具有口服活性,在小鼠哮喘加重模型中具有抗炎疗效,可用于治疗过敏性炎症。
为众多的药物研发团队赋能,
让新药发现更简单!
GJG057是一种高效和选择性的Leukotriene C4 synthase (LTC4S)抑制剂,在人全血LTC4释放试验中IC50=44 nM且具有口服活性,在小鼠哮喘加重模型中具有抗炎疗效,可用于治疗过敏性炎症。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,560 | In stock | |
5 mg | ¥ 3,780 | In stock | |
10 mg | ¥ 5,420 | In stock | |
25 mg | ¥ 8,130 | In stock | |
50 mg | ¥ 10,900 | In stock | |
100 mg | ¥ 14,800 | In stock | |
200 mg | ¥ 19,900 | In stock |
GJG057 相关产品
产品描述 | GJG057 is a highly efficient and selective Leukotriene C4 synthase (LTC4S) inhibitor with an IC50 of 44 nM in human whole blood LTC4 release assays and oral activity. It demonstrates anti-inflammatory efficacy in a mouse asthma exacerbation model and can be used for the treatment of allergic inflammation. |
靶点活性 | LTC4S:44nM |
别名 | GJG-057 |
分子量 | 456.41 |
分子式 | C21H21F5N4O2 |
CAS No. | 2761767-18-2 |
Smiles | O=C1N(C2=CC=C(F)C(F)=C2)C3(CCN(C=4N=CN=C(OCC(F)(F)F)C4)CC3)CCC1 |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 40.00 mg/mL (87.64 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容